CHA
GSK icon

Carmichael Hill & Associates’s GSK GSK Stock Holding History

Carmichael Hill & Associates’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-240
Closed -$11K – 767
2020
Q4 		$11K Hold
240
– – 0.01% 550
2020
Q3 		$11K Hold
240
– – 0.01% 512
2020
Q2 		$12K Hold
240
– – 0.01% 479
2020
Q1 		$11K Hold
240
– – 0.01% 445
2019
Q4 		$14K Buy
+240
New +$13.3K 0.01% 440

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Carmichael Hill & Associates's GSK Position: Q1 2021 in Review

Carmichael Hill & Associates sold out of GSK (GSK) in Q1 2021, closing a stake of 240 shares — an estimated $11K sold.

Carmichael Hill & Associates first reported a position in GSK in Q4 2019 and held it in 5 quarters. The position peaked at $14K in Q4 2019. 774 funds tracked by Wall St. Rank hold GSK as of Q1 2021.

  • Carmichael Hill & Associates reported no remaining GSK position as of Q1 2021 after selling out during the quarter.
  • Carmichael Hill & Associates sold 240 GSK shares in Q1 2021, an estimated $11K.
  • Carmichael Hill & Associates first reported a position in GSK in Q4 2019 and held it in 5 quarters.
  • Carmichael Hill & Associates's GSK position peaked at $14K in Q4 2019.
  • 774 funds tracked by Wall St. Rank held GSK as of Q1 2021.

Based on Carmichael Hill & Associates's 13F filing for Q1 2021, filed 28 Apr 2021.